复星医药

- 600196

-

-  -

-
昨收盘:- 今开盘:- 最高价:- 最低价:-
市值:-亿元 流通:- 成交:-手 换手:-
历年数据:  2025  2024  2023  2022  2021  2020  2019  2018  2017  2016  2015 
复星医药(600196) 利润表
单位:万元
报表日期2025-03-312024-12-312024-09-302024-06-302024-03-31
一、营业总收入942,032.284,106,719.593,091,188.902,046,281.271,015,725.53
营业收入942,032.284,106,719.593,091,188.902,046,281.271,015,725.53
二、营业总成本913,034.223,939,751.152,936,281.281,940,887.97952,243.35
营业成本492,029.602,136,557.401,588,959.961,046,338.55507,770.64
营业税金及附加9,642.8931,404.2023,382.8916,422.259,244.17
销售费用212,584.87867,976.38659,221.97426,627.08224,023.09
管理费用97,313.33428,325.73314,456.36206,443.17100,226.91
财务费用27,718.26111,051.8085,456.4758,883.3328,021.82
研发费用73,745.26364,435.65264,803.63186,173.5982,956.72
资产减值损失----------
公允价值变动收益-28,174.46-11,593.94-10,624.58-28,239.79-2,013.73
投资收益128,138.17210,460.74149,876.28106,176.6333,555.80
其中:对联营企业和合营企业的投资收益38,577.58164,383.88121,465.2384,132.0333,032.50
汇兑收益----------
三、营业利润135,877.12424,510.39310,758.88192,928.68102,136.41
加:营业外收入334.445,889.303,456.792,885.65931.41
减:营业外支出1,457.3713,471.537,059.082,694.251,225.43
其中:非流动资产处置损失----------
四、利润总额134,754.20416,928.17307,156.59193,120.08101,842.39
减:所得税费用40,597.5765,684.1355,304.8238,146.8823,220.27
五、净利润94,156.63351,244.04251,851.76154,973.2078,622.12
归属于母公司所有者的净利润76,475.78276,988.66201,064.24122,479.8660,973.36
少数股东损益17,680.8574,255.3850,787.5332,493.3417,648.75
六、每股收益
基本每股收益(元/股)0.29001.04000.75000.46000.2300
稀释每股收益(元/股)0.29001.04000.75000.46000.2300
七、其他综合收益-11,047.154,314.23-21,392.7311,241.999,115.42
八、综合收益总额83,109.47355,558.26230,459.03166,215.1987,737.54
归属于母公司所有者的综合收益总额65,201.53275,365.74183,339.47132,133.6868,523.31
归属于少数股东的综合收益总额17,907.9480,192.5247,119.5634,081.5119,214.23
下载全部历史数据到excel中 返回页顶